共 50 条
- [2] Analysis of Patients with Glioblastoma Treated with Standard 6-Week Chemoradiation Followed by Temozolomide: Treatment Outcomes and Prognostic Factors MEDICINA-LITHUANIA, 2025, 61 (03):
- [5] Partial response or better at 6 months is not shown to be a prognostic indicator of progression-free survival in Waldenstrom macroglobulinemia treated with acalabrutinib: a post hoc analysis CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S274 - S275
- [7] Faecal calprotectin identifies microscopic inflammation in ulcerative colitis patients with complete endoscopic healing: a post-hoc analysis of the MOMENTUM trial JOURNAL OF CROHNS & COLITIS, 2019, 13 : S169 - S169
- [10] Partial response or better at 6 months is not a prognostic indicator of progression-free survival in Waldenstrom macroglobulinemia treated with zanubrutinib: a post hoc analysis of the ASPEN study CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S274 - S274